Mugnaini Giovanni, Viggiano Domenico, Fontanari Paolo, Forzini Rossella, Voltolini Luca, Gonfiotti Alessandro
Thoracic Surgery Unit, Careggi University Hospital, Florence, Italy.
Department of Anhestesiology and Reanimation, Careggi University Hospital, Florence, Italy.
Front Surg. 2023 Feb 17;10:1120414. doi: 10.3389/fsurg.2023.1120414. eCollection 2023.
Awake minimally invasive Uniportal Video Assisted Thoracic Surgery (U-VATS) represents the last challenge in thoracic surgery that could change the future scenario for high comorbidity patients with early-stage non-small cell lung cancer (NSCLC). We report a single center preliminary experience of awake thoracoscopic uni-portal anatomic and non-anatomic sub-lobar resections in this setting.
We retrospectively analyzed data collected on a prospective database of patients undergoing U-VATS awake sub-lobar lung resections for NSCLC between September 2021 and September 2022. Inclusion criteria were clinical stage I disease; contraindication to standard lobectomy due to high respiratory function impairment; general anesthesia considered at high risk based on the American Society of Anesthesiologist score and on the Charlson Comorbidity Index. All patients underwent a standardized awake non-intubated anesthesia protocol approved by our institutional board.
They were = 10 patients: = 8 wedge resections; = 2 segmentectomies. We had = 1 (10%) conversion to standard general anesthesia and = 1 laryngeal mask support but maintaining spontaneous breathing. = 5 patients (50%) needed an Intensive Care Unit recovery (mean time = 17.20 h). Mean chest tube duration and Hospital stay were 2.0 and 3.5 days respectively. We did not register 30- days postoperative mortality.
Awake thoracic surgery is a feasible technique, and it could be performed also in high comorbidities' patients without a high rate of complications and allows to operate patients that so far were considered borderline for surgery.
清醒状态下的微创单孔电视辅助胸腔镜手术(U-VATS)是胸外科面临的最后一项挑战,它可能会改变早期非小细胞肺癌(NSCLC)高合并症患者的未来治疗前景。我们报告了在此背景下进行清醒胸腔镜单孔解剖性和非解剖性亚肺叶切除术的单中心初步经验。
我们回顾性分析了2021年9月至2022年9月期间在接受U-VATS清醒亚肺叶肺癌切除术患者的前瞻性数据库中收集的数据。纳入标准为临床I期疾病;由于高呼吸功能损害而禁忌标准肺叶切除术;根据美国麻醉医师协会评分和查尔森合并症指数,全身麻醉被认为风险较高。所有患者均接受了我们机构委员会批准的标准化清醒非插管麻醉方案。
共有10例患者:8例行楔形切除术;2例行肺段切除术。有1例(10%)转为标准全身麻醉,1例使用喉罩支持但维持自主呼吸。5例患者(50%)需要在重症监护病房恢复(平均时间=17.20小时)。平均胸管留置时间和住院时间分别为2.0天和3.5天。我们未记录到术后30天死亡率。
清醒胸外科手术是一种可行的技术,也可以在高合并症患者中进行,并发症发生率不高,并且能够对迄今为止被认为手术边缘的患者进行手术。